Clinical Trial Update: Investigation Of The Effect Of Steady State Filibuvir On The Pharmacokinetics Of Oral Contraceptives (Levonorgestrel And Ethinyl Estradiol) [Phase 1]

View source ↗

Summary

A Phase 1 trial assessed whether steady-state filibuvir alters the pharmacokinetics of oral contraceptives levonorgestrel and ethinyl estradiol in hepatitis C p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Filibuvir (filibuvir)
• Levonorgestrel (Levonorgestrel)
• ethinyl estradiol (ethinyl estradiol)

Snippet

Sponsor: Pfizer | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED